F.D.A. Approves New Obesity Drug That Will Compete With Wegovy

Health
By Gina Kolata from NYT Health https://ift.tt/OTpngq6
via IFTTT your-feed-science, Drugs (Pharmaceuticals), Semaglutide (Drug), Obesity, Weight Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda